A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 72,110 shares of ABT stock, worth $8.49 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
72,110
Previous 82,673 12.78%
Holding current value
$8.49 Million
Previous $8.59 Million 4.3%
% of portfolio
0.21%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $1.06 Million - $1.25 Million
-10,563 Reduced 12.78%
72,110 $8.22 Million
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $3.91 Million - $4.36 Million
-38,788 Reduced 31.93%
82,673 $8.59 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $402,924 - $445,011
-3,679 Reduced 2.94%
121,461 $13.8 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $2.53 Million - $3.1 Million
-28,089 Reduced 18.33%
125,140 $13.8 Million
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $1.81 Million - $2.18 Million
18,978 Added 14.14%
153,229 $14.8 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $12.1 Million - $13.4 Million
-119,753 Reduced 47.15%
134,251 $14.6 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $1.19 Million - $1.4 Million
12,283 Added 5.08%
254,004 $25.7 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $23,669 - $27,768
249 Added 0.1%
241,721 $26.5 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $2.28 Million - $2.64 Million
-23,538 Reduced 8.88%
241,472 $23.4 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $5.22 Million - $6.31 Million
-51,130 Reduced 16.17%
265,010 $28.8 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $2.49 Million - $3.03 Million
-21,827 Reduced 6.46%
316,140 $37.4 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $1.83 Million - $2.25 Million
-15,882 Reduced 4.49%
337,967 $47.6 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $812,303 - $898,644
-6,963 Reduced 1.93%
353,849 $41.8 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $11.4 Million - $13.4 Million
107,662 Added 42.53%
360,812 $41.8 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $2.86 Million - $3.37 Million
26,308 Added 11.6%
253,150 $30.3 Million
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $2.01 Million - $2.19 Million
19,183 Added 9.24%
226,842 $24.8 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $6.2 Million - $7.53 Million
67,700 Added 48.37%
207,659 $22.6 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $2.4 Million - $3.08 Million
-31,409 Reduced 18.33%
139,959 $12.8 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $1.74 Million - $2.54 Million
27,657 Added 19.24%
171,368 $13.5 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $116,273 - $129,439
1,481 Added 1.04%
143,711 $12.5 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $5.32 Million - $5.77 Million
-64,995 Reduced 31.36%
142,230 $11.9 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $1.07 Million - $1.25 Million
14,662 Added 7.61%
207,225 $17.4 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $140,849 - $170,287
-2,127 Reduced 1.09%
192,563 $15.4 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $3.06 Million - $3.47 Million
46,729 Added 31.58%
194,690 $14.1 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $3.32 Million - $3.67 Million
-57,712 Reduced 28.06%
147,961 $9.02 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $2.16 Million - $2.45 Million
38,463 Added 23.0%
205,673 $12.3 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $184,981 - $198,041
-3,446 Reduced 2.02%
167,210 $9.54 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $8.2 Million - $9.15 Million
170,656
170,656 $9.11 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.